A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer.
暂无分享,去创建一个
[1] J. Koopmeiners,et al. 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol and its Glucuronides in the Urine of Infants Exposed to Environmental Tobacco Smoke , 2006, Cancer Epidemiology Biomarkers & Prevention.
[2] S. Hecht,et al. Uptake of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone by Moldovan Children , 2006, Cancer Epidemiology Biomarkers & Prevention.
[3] D. Hatsukami,et al. Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers , 2005, Cancer Epidemiology Biomarkers & Prevention.
[4] E. A. Graham,et al. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. , 1950, Bulletin of the World Health Organization.
[5] S. Hecht,et al. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke , 2004, Tobacco Control.
[6] M. Thun,et al. Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.
[7] K. Anderson,et al. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] N. Fields,et al. Chasing Ernst L Wynder: 40 years of Philip Morris’ efforts to influence a leading scientist , 2003, Journal of epidemiology and community health.
[9] T. Church,et al. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[10] K. Anderson,et al. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. , 2001, Journal of the National Cancer Institute.
[11] S. Hecht,et al. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.
[12] S. Hecht,et al. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] E. Wynder,et al. Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers. , 1995, American journal of epidemiology.
[14] S. Hecht. Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology. , 1994, Journal of the National Cancer Institute.
[15] S. Hecht,et al. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. , 1993, The New England journal of medicine.
[16] S. Hecht,et al. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. , 1993, Cancer research.
[17] L. Anderson,et al. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. , 1993, Carcinogenesis.
[18] S. Amin,et al. Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. , 1990, Carcinogenesis.
[19] S. Belinsky,et al. Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1990, Cancer research.
[20] S. Hecht,et al. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.
[21] S. Hecht,et al. Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. , 1980, Cancer research.
[22] E. A. Graham,et al. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 1950, Journal of the American Medical Association.